Cloning and expression of gene fragment IgA-binding protein of group B streptococci.

Folia Microbiol (Praha)

Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg, Russia.

Published: February 2001

Different fragments of the bac gene coding for the IgA-binding protein were cloned, sequenced and expressed in E. coli. Cloning was accomplished after amplification of different parts of the gene by PCR. The 1.5-kb fragment of the gene was cloned using plasmid pBluescript. This fragment coded for the 45-kDa protein with the stable expression of IgA binding. In order to verify the exact location of the IgA-binding domain two smaller plasmids were constructed. Both plasmids were prepared using pQE30 (31, 32) expression vectors from Qiagen. The plasmids carried 245 and 123 bp bac gene fragments encoding 14- and 7-kDa proteins. These proteins together with the 20-amino-acid oligopeptide ITNEDKDSMLKKIEDINRQA were tested for IgA binding. Only the 14-kDa protein was able to bind IgA. This protein was used for rabbit immunization and found to be immunogenic. The data obtained lead to the conclusion that there is a lower limit in the size of recombinant IgA-binding proteins that can be utilized for anti-GBS vaccination.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02825670DOI Listing

Publication Analysis

Top Keywords

iga-binding protein
8
bac gene
8
iga binding
8
gene
5
protein
5
cloning expression
4
expression gene
4
gene fragment
4
iga-binding
4
fragment iga-binding
4

Similar Publications

Background And Objectives: Gut microbial symbionts have been shown to influence the development of autoimmunity in multiple sclerosis (MS). Emerging research points to an important relationship between the microbial-IgA interface and MS pathophysiology. IgA-secreting B cells are observed in the MS brain, and shifts in gut bacteria-IgA binding have been described in some patients with MS.

View Article and Find Full Text PDF

IgA, the primary human antibody secreted from the gut mucosa, shapes the intestinal microbiota. Methodological limitations have hindered defining which microbial strains are targeted by IgA and the implications of binding. Here we develop a technique, metagenomic immunoglobulin sequencing (MIg-seq), that provides strain-level resolution of microbes coated by IgA and use it to determine IgA coating levels for 3,520 gut microbiome strains in healthy human faeces.

View Article and Find Full Text PDF

IgA binding dictates the composition of the intestinal microbiome and reflects dysbiotic states during chronic disease. Both pathogenic and commensal bacteria differentially bind to IgA with varying outcomes. Little is known regarding IgA dynamics immediately following microbial dysbiosis.

View Article and Find Full Text PDF

Introduction: Equine asthma (EA) is a common lower airway disease in horses, but whether its pathogenesis is allergic is ambiguous. Extrinsic stimuli like hay dust induce acute exacerbation of clinical signs and sustained local neutrophilic inflammation in susceptible horses. is an EA stimulus, but it is unclear if it merely acts as an IgE-provoking allergen.

View Article and Find Full Text PDF

Introduction: IgA nephropathy (IgAN) is a kidney disorder characterized by the deposition of circulating immune complexes of IgG bound to galactose-deficient IgA1 (Gd-IgA1) in the mesangial glomeruli. However, limited research has been conducted on the levels of IgA binding in relation to the various sialylation profiles of IgG in IgAN.

Materials And Methods: Sialylated IgG (SA-IgG) and desialylated IgG (DSA-IgG) were isolated from IgAN patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!